Proto Labs, Inc.
PRLB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | -0.6% | 3.2% | 0.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 44.6% | 44.1% | 44.1% | 45.6% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 12.1% | 13.2% | -12% | 16.5% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 3.3% | 3.4% | -21.2% | 6.8% |
| EPS Diluted | 0.66 | 0.66 | -3.77 | 1.21 |
| % Growth | 0% | 117.5% | -411.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |